Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy. | Front Immunol | 2022 | 36479115 | PubTator, text mining | PubMed |
| Noncoding RNA in the Regulation of Acute Aortic Dissection: From Profile to Mechanism. | Cardiovasc Ther | 2022 | 36474715 | PubTator, text mining | PubMed |
| Inflammatory biomarkers after an exercise intervention in childhood acute lymphoblastic leukemia survivors. | EJHaem | 2022 | 36467791 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development. | Front Cell Dev Biol | 2022 | 36467412 | PubTator, text mining | PubMed |
| Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls. | Front Immunol | 2022 | 36466858 | PubTator, text mining | PubMed |
| A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer. | Front Immunol | 2022 | 36466815 | PubTator, text mining | PubMed |
| Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma. | Front Oncol | 2022 | 36465363 | PubTator, text mining | PubMed |
| Retraction Note: Hepatic stellate cell mediates transcription of TNFSF14 in hepatocellular carcinoma cells via H2S/CSE-JNK/JunB signaling pathway. | Cell Death Dis | 2022 | 36450708 | PubTator, text mining | PubMed |
| System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer. | Aging (Albany NY) | 2022 | 36445321 | PubTator, text mining | PubMed |
| Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. | Nat Commun | 2022 | 36443294 | PubTator, text mining | PubMed |
| The role of costimulatory molecules in glioma biology and immune microenvironment. | Front Genet | 2022 | 36437961 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study. | Cells | 2022 | 36429070 | PubTator, text mining | PubMed |
| Atopic Dermatitis: Clinical Aspects and Unmet Needs. | Biomedicines | 2022 | 36428493 | PubTator, text mining | PubMed |
| STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma. | BMC Cancer | 2022 | 36424540 | PubTator, text mining | PubMed |
| Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies. | Biology (Basel) | 2022 | 36421393 | PubTator, text mining | PubMed |
| A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators. | Front Genet | 2022 | 36406115 | PubTator, text mining | PubMed |
| A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. | Front Immunol | 2022 | 36405735 | PubTator, text mining | PubMed |
| Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation. | Front Immunol | 2022 | 36405728 | PubTator, text mining | PubMed |
| Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in non-small cell lung cancer. | J Transl Med | 2022 | 36401283 | PubTator, text mining | PubMed |
| MINERAL BONE DENSITY AND VITAMIN D LEVELS IN PATIENTS WITH PSORIATIC ARTHRITIS. | Acta Clin Croat | 2022 | 36398080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=26